Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome

COVID-19 patients can present with pulmonary edema early in disease. We propose that this is due to a local vascular problem because of activation of bradykinin 1 receptor (B1R) and B2R on endothelial cells in the lungs. SARS-CoV-2 enters the cell via ACE2 that next to its role in RAAS is needed to...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Veerdonk, Frank L, Netea, Mihai G, van Deuren, Marcel, van der Meer, Jos WM, de Mast, Quirijn, Brüggemann, Roger J, van der Hoeven, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2020
Materias:
Human Biology and Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213974/
https://www.ncbi.nlm.nih.gov/pubmed/32338605
http://dx.doi.org/10.7554/eLife.57555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213974/
https://www.ncbi.nlm.nih.gov/pubmed/32338605
http://dx.doi.org/10.7554/eLife.57555

Ejemplares similares